Efanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial Hypertrophy

Clinical trial NCT06941870 · RECRUITING

Trial details

NCT number: NCT06941870
Sponsor: Sanofi
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Factor VIII Deficiency

Start date: 2025-09-23
Primary completion: 2027-10-25
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.